Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRETIC: Pre-hospital RBC, Fibrinogen, and TXA for Trauma Hemorrhage
NCT03780894Phase 2Completed
- Sponsor
- Banc de Sang i Teixits
- Start
- Nov 2018
- Primary completion
- Jan 2021
- Modality
- Recombinant Proteins and Enzymes, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Fibrinogen human, red blood cells in traumatic hemorrhage, trauma-induced coagulopathy (TIC), sponsored by Banc de Sang i Teixits. Started Nov 2018; status: completed.
02
Drugs
Fibrinogen humanred blood cells
03
Conditions
traumatic hemorrhagetrauma-induced coagulopathy (TIC)
Beyond the preview
Go deeper on NCT03780894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03780894.